Exploratory Efficacy Endpoints News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exploratory Efficacy Endpoints. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exploratory Efficacy Endpoints Today - Breaking & Trending Today

Impressive Bleeding Profile With Factor XI Inhibitor in AF

Published: November 13, 2023

Further details from the phase 2b AZALEA trial of the factor XI inhibitor abelacimab show significant reductions in major and clinically relevant nonmajor bleeding vs rivaroxaban for patients with AF.

Source: medscape.com

Related Topics:

United StatesNorth CarolinaDuke UniversityJohn AlexanderManesh PatelAmerican Heart AssociationChristian RuffScientific SessionsExploratory Efficacy EndpointsMedscape CardiologyAtrial FibrillationF Atrial FibrillationAnticoagulation TherapyErebrovascular AccidentVa Cerebrovascular Accident Venous ThromboembolismBlood VesselsIschemic StrokeMonoclonal Antibody